FDA Updates Labeling Requirement In Emergency Blood Clot Detection Device Guidance
Executive Summary
The US agency added a minor update to the original guidance that broadens the labeling requirement for the devices to state they are only to be used as adjunctive diagnostics when evaluating a COVID-19 patient for risk of blood clots.